Cargando…
Microutrophin expression in dystrophic mice displays myofiber type differences in therapeutic effects
Gene therapy approaches for DMD using recombinant adeno-associated viral (rAAV) vectors to deliver miniaturized (or micro) dystrophin genes to striated muscles have shown significant progress. However, concerns remain about the potential for immune responses against dystrophin in some patients. Utro...
Autores principales: | Banks, Glen B., Chamberlain, Jeffrey S., Odom, Guy L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682874/ https://www.ncbi.nlm.nih.gov/pubmed/33175853 http://dx.doi.org/10.1371/journal.pgen.1009179 |
Ejemplares similares
-
Myofiber branching rather than myofiber hyperplasia contributes to muscle hypertrophy in mdx mice
por: Faber, Rachel M, et al.
Publicado: (2014) -
Therapeutic potential of highly functional codon-optimized microutrophin for muscle-specific expression
por: Starikova, Anna V., et al.
Publicado: (2022) -
Extensive but Coordinated Reorganization of the Membrane Skeleton in Myofibers of Dystrophic (mdx) Mice
por: Williams, McRae W., et al.
Publicado: (1999) -
Fukutin is prerequisite to ameliorate muscular dystrophic phenotype by myofiber-selective LARGE expression
por: Ohtsuka, Yoshihisa, et al.
Publicado: (2015) -
Muscle Structure Influences Utrophin Expression in mdx Mice
por: Banks, Glen B., et al.
Publicado: (2014)